Parsons R, Myeroff L L, Liu B, Willson J K, Markowitz S D, Kinzler K W, Vogelstein B
Johns Hopkins Oncology Center, Baltimore, Maryland 21231, USA.
Cancer Res. 1995 Dec 1;55(23):5548-50.
The TGF beta type II receptor (RII) was found to be mutated within a polyadenine tract in 100 of 111 (90%) colorectal cancers with microsatellite instability. Other polyadenine tracts of similar length were mutated in these samples but not as frequently as RII. In most cases, the polyadenine tract mutations affected both alleles of RII, and in four tumors heterozygous for the polyadenine mutations, three had additional mutations that were expected to inactivate the other RII allele. These genetic data support the idea that RII behaves like a tumor suppressor during CR cancer development and is a critical target of inactivation in mismatch repair-deficient tumors.
在111例微卫星不稳定的结直肠癌中,有100例(90%)的转化生长因子β II型受体(RII)在一个多聚腺嘌呤序列中发生了突变。在这些样本中,其他长度相似的多聚腺嘌呤序列也发生了突变,但频率不如RII高。在大多数情况下,多聚腺嘌呤序列突变影响了RII的两个等位基因,在4例多聚腺嘌呤突变杂合的肿瘤中,有3例发生了额外的突变,预计这些突变会使另一个RII等位基因失活。这些遗传学数据支持了这样一种观点,即在结直肠癌发生过程中,RII表现得像一个肿瘤抑制因子,并且是错配修复缺陷肿瘤中失活的关键靶点。